Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
AKRO holding history
Akero Therapeutics, Inc. in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AKRO overviewAll 13F holders of AKROFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −527,004−100.0% | Sold out | Holders |
| Q1 2025 | 527,004 | $21.3M | 0.1% | +527,004 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −779,126−100.0% | Sold out | Holders |
| Q3 2023 | 779,126 | $39.4M | 0.1% | +472,898+154.4% | Added | Holders |
| Q2 2023 | 306,228 | $14.3M | <0.1% | +306,228 | New | Holders |